These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2727988)

  • 21. Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.
    Takeda Y; Nishio K; Sugimoto Y; Kasahara K; Kubo S; Fujiwara Y; Niitani H; Saijo N
    Int J Cancer; 1991 Jul; 48(6):931-7. PubMed ID: 1677641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
    Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
    Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced topoisomerase II-mediated DNA cleavage in VP-16 resistant human leukemic cell line.
    Saijo Y; Satoh K; Tokue Y; Kumano N; Motomiya M
    Anticancer Res; 1991; 11(1):445-8. PubMed ID: 1850222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a human myeloid leukemia cell line highly resistant to taxol.
    Bhalla K; Huang Y; Tang C; Self S; Ray S; Mahoney ME; Ponnathpur V; Tourkina E; Ibrado AM; Bullock G
    Leukemia; 1994 Mar; 8(3):465-75. PubMed ID: 7907395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
    Chao NJ; Aihara M; Blume KG; Sikic BI
    Exp Hematol; 1990 Dec; 18(11):1193-8. PubMed ID: 2226679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines].
    Nagasawa M; Ishii S; Kariya Y; Itoh O; Yamamoto H; Kawaharajo K; Takeuchi T
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):633-8. PubMed ID: 2108612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased levels of mitochondrial DNA in an etoposide-resistant human monocytic leukaemia cell line (THP-1/E).
    Tokue Y; Saijo Y; Satoh K; Motomiya M
    Eur J Cancer; 1991; 27(11):1436-40. PubMed ID: 1835860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined modalities of resistance in etoposide-resistant human KB cell lines.
    Ferguson PJ; Fisher MH; Stephenson J; Li DH; Zhou BS; Cheng YC
    Cancer Res; 1988 Nov; 48(21):5956-64. PubMed ID: 2844393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of antitumor activity rhizoxin for human lung cancer cell lines: a potent new drug for drug-resistant lung cancer].
    Takigawa N; Ohnoshi T; Ueoka H; Horiguchi T; Kiura K; Tabata M; Segawa Y; Shibayama T; Genba K; Matsumura T
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1221-6. PubMed ID: 8392827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line.
    Takigawa N; Ohnoshi T; Ueoka H; Kiura K; Kimura I
    Acta Med Okayama; 1992 Jun; 46(3):203-12. PubMed ID: 1354408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
    Ritke MK; Murray NR; Allan WP; Fields AP; Yalowich JC
    Mol Pharmacol; 1995 Nov; 48(5):798-805. PubMed ID: 7476909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection.
    Andoh T; Nishizawa M; Hida T; Ariyoshi Y; Takahashi T; Ueda R
    Oncol Res; 1996; 8(6):229-38. PubMed ID: 8895198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype.
    Matsumoto Y; Takano H; Fojo T
    Cancer Res; 1997 Nov; 57(22):5086-92. PubMed ID: 9371507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.
    Danks MK; Schmidt CA; Cirtain MC; Suttle DP; Beck WT
    Biochemistry; 1988 Nov; 27(24):8861-9. PubMed ID: 2853972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of an etoposide-resistant human K562 cell line, K/eto.
    Sugawara I; Iwahashi T; Okamoto K; Sugimoto Y; Ekimoto H; Tsuruo T; Ikeuchi T; Mori S
    Jpn J Cancer Res; 1991 Sep; 82(9):1035-43. PubMed ID: 1657846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.
    Takano H; Kohno K; Ono M; Uchida Y; Kuwano M
    Cancer Res; 1991 Aug; 51(15):3951-7. PubMed ID: 1649696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
    Jensen PB; Christensen IJ; Sehested M; Hansen HH; Vindeløv L
    Br J Cancer; 1993 Feb; 67(2):311-20. PubMed ID: 8094293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etoposide inhibition of methylaminoisobutyric acid transport and its recovery in K562 cells.
    Shionoya S
    Leuk Res; 1991; 15(2-3):137-41. PubMed ID: 2016905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: implications for etoposide resistance.
    Eliot HE; Borner MM; Sinha BK
    Anticancer Res; 1995; 15(3):729-33. PubMed ID: 7645949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II.
    Campain JA; Padmanabhan R; Hwang J; Gottesman MM; Pastan I
    J Cell Physiol; 1993 May; 155(2):414-25. PubMed ID: 8097746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.